- Home
- FBIN vs CORT Comparison
FBIN vs CORT Comparison
Compare FBIN & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIN
- CORT
- Stock Information
- Founded
- FBIN 1988
- CORT 1998
- Country
- FBIN United States
- CORT United States
- Employees
- FBIN N/A
- CORT N/A
- Industry
- FBIN Building Products
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- FBIN Consumer Discretionary
- CORT Health Care
- Exchange
- FBIN Nasdaq
- CORT Nasdaq
- Market Cap
- FBIN 7.3B
- CORT 7.6B
- IPO Year
- FBIN N/A
- CORT N/A
- Fundamental
- Price
- FBIN $57.51
- CORT $79.80
- Analyst Decision
- FBIN Buy
- CORT Strong Buy
- Analyst Count
- FBIN 11
- CORT 4
- Target Price
- FBIN $75.45
- CORT $139.00
- AVG Volume (30 Days)
- FBIN 1.5M
- CORT 720.7K
- Earning Date
- FBIN 11-05-2025
- CORT 10-29-2025
- Dividend Yield
- FBIN 1.75%
- CORT N/A
- EPS Growth
- FBIN N/A
- CORT N/A
- EPS
- FBIN 3.18
- CORT 1.11
- Revenue
- FBIN $4,496,000,000.00
- CORT $716,080,000.00
- Revenue This Year
- FBIN $0.72
- CORT $30.62
- Revenue Next Year
- FBIN $3.19
- CORT $37.68
- P/E Ratio
- FBIN $17.97
- CORT $71.25
- Revenue Growth
- FBIN N/A
- CORT 25.71
- 52 Week Low
- FBIN $47.21
- CORT $40.15
- 52 Week High
- FBIN $90.54
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- FBIN 47.05
- CORT 68.64
- Support Level
- FBIN $56.45
- CORT $69.03
- Resistance Level
- FBIN $59.80
- CORT $74.79
- Average True Range (ATR)
- FBIN 1.58
- CORT 2.93
- MACD
- FBIN -0.38
- CORT 0.73
- Stochastic Oscillator
- FBIN 20.58
- CORT 98.97
About FBIN Fortune Brands Innovations Inc.
Fortune Brands Innovations is a leading home and security products company that has three reportable segments. The company's $2.6 billion water segment, led by the Moen brand, sells faucets, showers, and other plumbing fixtures; the $1.4 billion outdoors segment primarily sells entry doors under the Therma-Tru brand name and Fiberon-branded patio decking; and the $700 million security segment sells locks and other security devices under the Master Lock, SentrySafe, Yale, and August brand names.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.